Newborn Screening Market on Upward Trajectory, Expected to Reach $2.0 Billion by 2031

Newborn screening identifies conditions that can affect a child's long-term health or survival. This screening technology includes a series of tests essential for timely detection, early diagnosis, and health management to prevent overall disability and avert death of a child. These tests are performed shortly after the baby is born, and detect genetic, developmental, and metabolic disorders in newborn babies. The global newborn screening market was valued at $1.1 billion in 2021, and is projected to reach $2.0 billion by 2031, growing at a CAGR of 6.8% from 2022 to 2031.

Request Sample Copy of Report:
https://www.alliedmarketresearch.com/request-sample/1049

COVID-19 Impact Analysis (Pre & Post) -

• The Covid-19 pandemic had a negative impact on the newborn screening market, as the majority of the screening centers experienced a broad spectrum of difficulties and most were affected during the pandemic.
• Availability of laboratory equipment and reagents was also delayed due to postal delays and unreliability, as well as flight cancellation.

The blood sample is screened for a variety of conditions, including but not limited to:

• Phenylktonuria (PKU)
• Hypothyroidism
• Galactosemia
• Sickle cell disease
• Cystic fibrosis
• Maple syrup urine disease
• Congenital adrenal hyperplasia
• Biotinidase deficiency

If the screening test indicates that the baby may have a condition, further testing is usually needed to confirm the diagnosis. If the diagnosis is confirmed, treatment can begin as soon as possible to prevent or minimize the risk of complications.

Procure Complete Report (220 Pages PDF with Insights, Charts, Tables, and Figures) @
https://www.alliedmarketresearch.com/checkout-final/6939a226ebd5f396def6baae3ae0e64b

Important Key Market Players Are -

• Ge Healthcare,
• Trivitron Healthcare,
• Bio-Rad Laboratories Inc.,
• Covidien Plc,
• Natus Medical Incorporated,
• Ab Sciex LLC,
• Waters Corporation,
• MASIMO CORPORATION,
• Agilent Technologies Inc.,
• PERKINELMER, INC.

Newborn screening is a routine part of healthcare in many countries and is generally considered to be safe and effective. Early detection and treatment can help prevent serious health problems and improve outcomes for infants with these conditions. It's important to note that newborn screening is not a diagnosis and further testing may be required to confirm or rule out a condition.

Key Findings of The Study -

• Based on product, the consumables held the largest market share in 2021 and is expected to remain dominant during the forecast period.
• Based on test, the blood test segment held the largest share in the global market in 2021
• On the basis of technology, the tandem mass spectrometry (TMS) held the largest market share in 2021 and is expected to remain dominant during the forecast period.

For Purchase Inquiry of Report:
https://www.alliedmarketresearch.com/purchase-enquiry/1049

Geographic Segments Covered in the Report -

The Newborn Screening Market report provides information about the market area, which is further subdivided into sub-regions and countries/regions. In addition to the market share in each country and sub-region, this chapter of this report also contains information on profit opportunities. This chapter of the report mentions the market share and growth rate of each region, country, and sub-region during the estimated period.

• North America (USA and Canada)

• Europe (UK, Germany, France and the rest of Europe)

• Asia Pacific (China, Japan, India, and the rest of the Asia Pacific region)

• Latin America (Brazil, Mexico, and the rest of Latin America)

• Middle East and Africa (GCC and rest of the Middle East and Africa)

Frequently Asked Questions?

1. What is newborn screening and why is it important for infants?
2. What conditions are typically screened for during newborn screening tests?
3. How is newborn screening performed and what does the process entail?
4. What are the benefits of early detection through newborn screening?
5. Are newborn screening tests mandatory, and are there any risks or limitations associated with them?

Contact Us:

United States
1209 Orange Street,
Corporation Trust Center,
Wilmington, New Castle,
Delaware 19801 USA.
Int'l: +1-503-894-6022
Toll Free: +1-800-792-5285
Fax: +1-800-792-5285
help@alliedmarketresearch.com

About Us -

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Pawan Kumar, the CEO of Allied Market Research is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various research data tables and confirms utmost accuracy in our market forecasting. Each and every us companies and this helps us in digging out market data that helps us generate accurate y data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

This release was published on openPR.